|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||78.74 - 80.09|
|52 Week Range||69.35 - 89.72|
|PE Ratio (TTM)||26.76|
|Earnings Date||Nov 21, 2017|
|Forward Dividend & Yield||1.84 (2.32%)|
|1y Target Est||89.56|
Medtronic will overcome Hurricane Maria's impact in fiscal 2018, but the company faces growing competition in heart implants.
ZBH stock has a “buy” rating from 18 (64%) analysts. Nine (32%) analysts gave ZBH a “hold” rating, and one gave it a “sell” rating.
Divestiture of certain businesses to Cardinal Health induces year-over-year decline in Medtronic's (MDT) preliminary sales figure. However, impact of Maria is likely to be lighter on the company's finances.
DUBLIN - November 13, 2017 - Medtronic plc (NYSE: MDT) today announced several noteworthy presentations of clinical studies and symposia on aortic, peripheral, endoVenous, and vascular embolization therapies ...
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Medtronic Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)
Medtronic said Wednesday that Hurricane Maria dealt less damage to its business than many had feared in the aftermath of the hurricane's devastation of Puerto Rico, where Medtronic and many other med-tech companies have manufacturing facilities. The company, reporting its preliminary results for its fiscal second quarter, said that the hurricane shut down four Medtronic facilities and reduced sales by $55 million to $65 million as production was interrupted. Earlier, it had estimated the business impact from Maria could be as high as $250 million.
Hurricane Maria wiped out Puerto Rico, but the financial impact on Medtronic Plc was a lot lower than the medical device maker anticipated a month ago.
Preliminary Revenue of Approximately $7.1 Billion Company Updates Hurricane Maria Impact to Second Quarter Financial Results Company Reiterates Second Quarter EPS Expectations Excluding Hurricane Maria ...
Solid growth at Medical Segment drove Cardinal Health's (CAH) first-quarter results. Product launches and completion of strategic acquisitions in the quarter are major positives.
Medtronic plc (NYSE: MDT ) today announced that it received CE (Conformité Européenne) Mark for the Intellis(TM) platform for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) as ...
New Neurostimulation System Is a Non-Opioid Alternative for Chronic Pain and Offers Personalized Pain Relief and Advanced Activity Tracking DUBLIN - November 6, 2017 - Medtronic plc (NYSE:MDT) today announced ...
It may be easier than ever for Medtronic to sell the spine surgery robots made by this tiny upstart.
Today we’re going to take a look at the well-established Medtronic plc (NYSE:MDT). The company’s stock maintained its current share price over the past couple of month on the NYSE,Read More...
Stents, the tiny wire cases made by companies such as Medtronic and Boston Scientific, are used in hundreds of thousands of patients each year to treat nonemergency chest pain. The New York Times reports on the surprising findings , which upend years of commonly held assumptions about stents, which prop open partially blocked arteries to — it was believed — ease chest pain during exercise. Stents are still thought to be life-savers when it comes to emergency procedures — when a patient is having a heart attack.
Report Highlights Company`s Global Financial, Social, and Environmental Impact DUBLIN - November 2, 2017 - Medtronic plc (NYSE:MDT) announces the release of its fiscal year 2017 Integrated Performance ...
Evolut PRO Valve Well-Positioned for Future with New Study Unveiled to Investigate Expanded Patient Population DUBLIN and DENVER - November 2, 2017 - Medtronic plc (NYSE:MDT) today presented new data at ...
First Report Investigation at TCT Published in JACC Shows Substantial Mitral Valve Regurgitation Reductions and Versatility of Dual-Stent Design DUBLIN and DENVER - November 1, 2017 - Medtronic plc (NYSE:MDT) ...
DAPT-STEMI Late-Breaker at TCT Reveals Results of Shortened DAPT Duration in Higher-Risk Patients DUBLIN and DENVER - November 1, 2017 - Investigators today unveiled clinical data from the independently ...
Sofinnova Partners is betting again on an entrepreneur behind CoreValve Inc., a medical-device company acquired by Medtronic PLC for more than $700 million in 2009.